Health
COVID-19 drug remdesivir has been a big win for Gilead — and it got a boost from taxpayers – San Francisco Chronicle
With U.S. cases skyrocketing, demand for the Foster City company’s antiviral drug is only growing. Biden appointees have proposed potential legal tactics to tamp…
It was the end of April — just as the U.S. confirmed its millionth COVID-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir.
That was surprising because the antiviral drug, owned by Gilead Sciences and developed with investment from the federal government, had languished for years with no apparent commercial use. It had struck out as a treatment for hepatitis C and Ebola.
But early in 2020, when the first global…
-
Noosa News23 hours agoToyah Cordingley’s accused killer Rajwinder Singh had sand ‘scattered’ throughout car, Cairns court hears
-
Noosa News8 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
Noosa News24 hours agoAcademics hit back after leading universities oppose key environmental legislation
-
Business23 hours ago3 top ASX ETFs to buy for your SMSF in December